Sky Labs Secures Investment from OMRON Ventures for Global Expansion

Sky Labs has secured a significant investment from OMRON Ventures, the venture capital arm of OMRON Group, aimed at enhancing its global business reach. The announcement was made on November 4, 2025, during an event in Seoul, South Korea. This partnership not only represents a financial investment but also a strategic collaboration focused on expanding Sky Labs’ innovative healthcare solutions worldwide.

In conjunction with this investment, Sky Labs signed a Memorandum of Understanding (MoU) with OMRON Healthcare Co., Ltd., a leader in the global blood pressure monitoring market. This agreement underscores the companies’ commitment to strengthening their partnership and collaborating on the development and distribution of Sky Labs’ cutting-edge product, the CART BP.

The CART BP device is notable for being the world’s first cuffless, ring-type blood pressure monitor. It allows for continuous measurement of blood pressure throughout daily activities, including during sleep. This innovative technology is designed to help prevent chronic conditions such as hypertension and cardiovascular disease by providing users with detailed insights into their blood pressure trends over time.

OMRON Healthcare, based in Muko, Kyoto, has established itself as an industry leader, supplying blood pressure monitors and cardiovascular management solutions to over 130 countries. With cumulative global sales exceeding 400 million units as of 2025, OMRON is committed to ongoing innovation in the field of blood pressure management.

Jack Byunghwan Lee, CEO of Sky Labs, expressed enthusiasm about the partnership, stating, “Our strategic partnership is an achievement in which Sky Labs’ technology has been recognized for both clinical effectiveness and business feasibility in global standards. We will lead innovation in the global healthcare market by expanding chronic disease management along with OMRON Healthcare.”

Sky Labs, founded in September 2015, is known for developing innovative healthcare technologies. The company initially created the CART (Cardio Tracker), a device designed for monitoring heart signals through optical sensors. Building on this foundation, Sky Labs introduced the CART BP, which aims to significantly enhance the quality of life for individuals with hypertension by providing continuous, accurate blood pressure data.

In addition to its partnership with OMRON, Sky Labs has established an exclusive domestic distribution agreement with South Korea’s Daewoong Pharmaceutical. This agreement paves the way for wide distribution of CART BP across hospitals, clinics, and general consumers in South Korea.

The collaboration between Sky Labs and OMRON Healthcare represents a significant step forward in the fight against chronic diseases and highlights the potential of technology in revolutionizing healthcare delivery. As both companies continue to innovate, the global healthcare market can anticipate exciting developments aimed at improving patient outcomes and enhancing disease management.